Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1434-1436

  Park, John K ^a   Clark, Rachel ^b   Session, Donna R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MENOTROPINS; MULTIVARIATE ANALYSIS; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PREGNANCY, MULTIPLE; RETROSPECTIVE STUDIES;

EID: 63249091724     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.017     Document Type: Article

References (7)

1. Corfman R., Milad M., Bellavance T., Ory S., Erickson L., and Ball G. A novel ovarian stimulation protocol for use with the assisted reproductive technologies. Fertil Steril 60 (1993) 864-870
2. Lu P., Chen A., Atkinson E., Lee S., Erickson L., and Ory S. Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility. Fertil Steril 65 (1996) 583-587
3. Dhaliwal L., Sialy R., Gopalan S., and Majumdar S. Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility. J Obstet Gynaecol Res 28 (2002) 295-299
4. Platteau P., Andersen A., Balen A., Devroey P., Sorensen P., Helmgaard L., et al. Similar ovulation rates, but different follicular development, with highly purified menotrophin compared with recombinant FSH in WHO group II anovulatory infertility: a randomized controlled study. Hum Reprod 21 (2006) 1798-1804
5. Filicori M., Cognigni G., Pocognoli P., Taberelli C., Ferlini F., Perri T., et al. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril 80 (2003) 390-397
6. Loumaye E., Engrand P., Shoham Z., Hillier S., and Baird D. Clinical evidence for an LH "ceiling" effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 18 (2003) 314-322
7. Andersen A., Devroey P., and Arce J. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 21 (2006) 3217-3227